Literature DB >> 15731225

Genetic analysis of the human papillomavirus type 31 differentiation-dependent late promoter.

Jason M Bodily1, Craig Meyers.   

Abstract

Human papillomaviruses infect stratifying squamous epithelia, causing benign and malignant lesions. Upon differentiation of the host keratinocyte, the virus undergoes a dramatic increase in both DNA replication and transcription from the late promoter, leading to expression of late genes and virion morphogenesis. In human papillomavirus type 31 (HPV31), the late promoter is designated p742 and includes multiple start sites embedded within the E7 gene. In this report, we mapped viral DNA elements that control transcriptional activity from p742. Enhancer elements in the viral upstream regulatory region positively regulate this promoter. The region containing the transcriptional start sites is dispensable for activity, and at least two separate elements in the E6/E7 region are capable of supporting transcription. Of these, we mapped one to a 150-bp region of the E7 open reading frame and designate it the core p742 promoter. Using GF109203X, an inhibitor of protein kinase C signaling, we show that p742 activation is independent of viral genome amplification. Finally, we mapped elements in the region of p742 that confer responsiveness to differentiation and show that the upstream regulatory region does not contribute to the differentiation response of p742. These studies are an important step toward understanding the functioning and regulation of this multiple-start promoter.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15731225      PMCID: PMC1075705          DOI: 10.1128/JVI.79.6.3309-3321.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

1.  A constitutive enhancer in the bovine papillomavirus upstream regulatory region shares genetic elements with the viral P1 promoter.

Authors:  G L Bream; P Vaillancourt; M R Botchan
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

Review 2.  Papillomaviruses in human cancers.

Authors:  H zur Hausen
Journal:  Proc Assoc Am Physicians       Date:  1999 Nov-Dec

3.  Transcriptional activity of human papillomavirus type 31b enhancer is regulated through synergistic interaction of AP1 with two novel cellular factors.

Authors:  S Kyo; A Tam; L A Laimins
Journal:  Virology       Date:  1995-08-01       Impact factor: 3.616

Review 4.  The role of general initiation factors in transcription by RNA polymerase II.

Authors:  R G Roeder
Journal:  Trends Biochem Sci       Date:  1996-09       Impact factor: 13.807

5.  Start site selection by Sp1 in the TATA-less human Ha-ras promoter.

Authors:  J Lu; W Lee; C Jiang; E B Keller
Journal:  J Biol Chem       Date:  1994-02-18       Impact factor: 5.157

6.  Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNA.

Authors:  K Grassmann; B Rapp; H Maschek; K U Petry; T Iftner
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

7.  The role of the E1 and E2 proteins in the replication of human papillomavirus type 31b.

Authors:  M G Frattini; L A Laimins
Journal:  Virology       Date:  1994-11-01       Impact factor: 3.616

8.  Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53.

Authors:  D H Mack; J Vartikar; J M Pipas; L A Laimins
Journal:  Nature       Date:  1993-05-20       Impact factor: 49.962

9.  Differentiation-specific alternative splicing of bovine papillomavirus late mRNAs.

Authors:  S Barksdale; C C Baker
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

10.  Human papillomavirus type 31b late gene expression is regulated through protein kinase C-mediated changes in RNA processing.

Authors:  M Hummel; H B Lim; L A Laimins
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more
  23 in total

Review 1.  Papillomavirus genome structure, expression, and post-transcriptional regulation.

Authors:  Zhi-Ming Zheng; Carl C Baker
Journal:  Front Biosci       Date:  2006-09-01

2.  Regulation of human papillomavirus type 31 gene expression during the differentiation-dependent life cycle through histone modifications and transcription factor binding.

Authors:  Tonia R Wooldridge; Laimonis A Laimins
Journal:  Virology       Date:  2008-01-31       Impact factor: 3.616

3.  Regulation of the human papillomavirus type 16 late promoter by transcriptional elongation.

Authors:  William K Songock; Matthew L Scott; Jason M Bodily
Journal:  Virology       Date:  2017-04-24       Impact factor: 3.616

4.  Differentiation-dependent changes in levels of C/EBPβ repressors and activators regulate human papillomavirus type 31 late gene expression.

Authors:  Vignesh Gunasekharan; Guylaine Haché; Laimonis Laimins
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

5.  Study of infectious virus production from HPV18/16 capsid chimeras.

Authors:  Horng-Shen Chen; Jennifer Bromberg-White; Michael J Conway; Samina Alam; Craig Meyers
Journal:  Virology       Date:  2010-07-03       Impact factor: 3.616

6.  Suppression of Stromal Interferon Signaling by Human Papillomavirus 16.

Authors:  Gaurav Raikhy; Brittany L Woodby; Matthew L Scott; Grace Shin; Julia E Myers; Rona S Scott; Jason M Bodily
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

7.  Human papillomavirus type 18 chimeras containing the L2/L1 capsid genes from evolutionarily diverse papillomavirus types generate infectious virus.

Authors:  Brian S Bowser; Horng-Shen Chen; Michael J Conway; Neil D Christensen; Craig Meyers
Journal:  Virus Res       Date:  2011-07-06       Impact factor: 3.303

8.  Characterization of the Human Papillomavirus 16 E8 Promoter.

Authors:  Elke Straub; Jasmin Fertey; Marcel Dreer; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2015-05-06       Impact factor: 5.103

9.  An interaction between human papillomavirus 16 E2 and TopBP1 is required for optimum viral DNA replication and episomal genome establishment.

Authors:  Mary M Donaldson; Lorna J Mackintosh; Jason M Bodily; Edward S Dornan; Laimonis A Laimins; Iain M Morgan
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

10.  Treatment of a human papillomavirus type 31b-positive cell line with benzo[a]pyrene increases viral titer through activation of the Erk1/2 signaling pathway.

Authors:  Brian S Bowser; Samina Alam; Craig Meyers
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.